Home · Health · Sep 18 archive

Muscle Loss Linked to Higher Dementia Risk

Confirmed

Health Desk

In Short: New research suggests that muscle loss in middle age is associated with a higher risk of developing dementia.

According to a study published in the International Journal of Food Sciences and Nutrition, muscle loss and reduced muscle strength in middle age are linked to a higher risk of developing dementia.

The research, led by Curtin University, analyzed more than 80 long-term studies and found that people with sarcopenia, a condition characterized by low muscle mass, reduced strength, or poor physical function, had a 42 percent higher risk of developing dementia.

Dr. Booranasuksakul, a researcher involved in the study, emphasized the importance of maintaining muscle strength and function as we age.

The study also revealed that obesity before the age of 65 was associated with a nine percent higher risk of dementia, while obesity in later life showed the opposite pattern, with a 17 percent lower risk.

Tests of strength and physical function showed clearer links with dementia than muscle measurements alone.

The study also highlighted that muscle health showed a more consistent relationship with dementia risk than obesity did.

The research challenges the idea that dementia risk can be understood simply by looking at a person’s weight.

The study, titled 'Sarcopenia, Obesity, Sarcopenic Obesity and Dementia Risk: A Systematic Review and Meta-Analysis of Cohort Studies,' underscores the importance of maintaining a healthy body composition throughout life.

What this adds

The study adds to the understanding that muscle loss and reduced muscle strength in middle age are significant risk factors for dementia, highlighting the need for early detection and intervention.

The research also suggests that muscle health may play a more critical role in dementia risk than previously thought, challenging the traditional focus on body weight and obesity.

Background

Scholar Rock's Isembyld, the first drug to target spinal muscle atrophy muscle loss, has received FDA approval, raising hopes for improved mobility in patients.

What's confirmed

What's still developing

Sources